相似文献
1
New and Emerging Technologies in Type 1 Diabetes.
Endocrinol Metab Clin North Am. 2020 Dec;49(4):667-678. doi: 10.1016/j.ecl.2020.07.006. Epub 2020 Oct 14.
2
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-243. doi: 10.1016/S2213-8587(15)00489-1. Epub 2016 Feb 3.
3
Diabetes technology and treatments in the paediatric age group.
Int J Clin Pract Suppl. 2011 Feb(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x.
4
Closed loop insulin delivery in diabetes.
Best Pract Res Clin Endocrinol Metab. 2015 Jun;29(3):315-25. doi: 10.1016/j.beem.2015.03.001. Epub 2015 Mar 10.
5
Current management of diabetes mellitus and future directions in care.
Postgrad Med J. 2015 Nov;91(1081):612-21. doi: 10.1136/postgradmedj-2014-133200. Epub 2015 Oct 9.
6
Perioperative Considerations for Evolving Artificial Pancreas Devices.
Anesth Analg. 2019 May;128(5):902-906. doi: 10.1213/ANE.0000000000003779.
7
[What is the current state of the artificial pancreas in diabetes care?].
Internist (Berl). 2020 Jan;61(1):102-109. doi: 10.1007/s00108-019-00713-y.
8
The Impact of Technology on Current Diabetes Management.
Pediatr Clin North Am. 2015 Aug;62(4):873-88. doi: 10.1016/j.pcl.2015.04.005. Epub 2015 May 16.
9
Emerging diabetes therapies and technologies.
Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. doi: 10.1016/j.diabres.2012.01.027. Epub 2012 Feb 29.
10
Automatic data processing to achieve a safe telemedical artificial pancreas.
J Diabetes Sci Technol. 2009 Sep 1;3(5):1039-46. doi: 10.1177/193229680900300507.
引用本文的文献
1
Monitoring Lipolysis by Sensing Breath Acetone down to Parts-per-Billion.
Small Sci. 2021 Mar 12;1(4):2100004. doi: 10.1002/smsc.202100004. eCollection 2021 Apr.
2
The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose Sensors.
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70047. doi: 10.1002/edm2.70047.
3
Use of Digital Health Interventions for Cancer Prevention Among People Living With Disabilities in the United States: A Scoping Review.
Cancer Med. 2025 Jan;14(2):e70571. doi: 10.1002/cam4.70571.
4
Impact of Probiotics on the Glycemic Control of Pediatric and Adolescent Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis.
Nutrients. 2024 Aug 9;16(16):2629. doi: 10.3390/nu16162629.
5
Navigating Cardiovascular Risk in Type 1 Diabetes: A Comprehensive Review of Strategies for Prevention and Management.
Cureus. 2024 May 16;16(5):e60426. doi: 10.7759/cureus.60426. eCollection 2024 May.
6
"Obviously, Nothing's Gonna Happen in Five Minutes": How Adolescents and Young Adults Infrastructure Resources to Learn Type 1 Diabetes Management.
Proc SIGCHI Conf Hum Factor Comput Syst. 2024 May;2024. doi: 10.1145/3613904.3642612. Epub 2024 May 11.
7
"I'm Staring at the Screen All the Time": Technology Use and Mindfulness in Adolescents with Type 1 Diabetes.
Compr Child Adolesc Nurs. 2024 Jun;47(2):98-114. doi: 10.1080/24694193.2024.2351909. Epub 2024 May 29.
8
The emergence of obesity in type 1 diabetes.
Int J Obes (Lond). 2024 Mar;48(3):289-301. doi: 10.1038/s41366-023-01429-8. Epub 2023 Dec 14.
9
Sex- and Age Group-Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus.
JBMR Plus. 2023 Oct 27;7(11):e10836. doi: 10.1002/jbm4.10836. eCollection 2023 Nov.
10
Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial.
Front Endocrinol (Lausanne). 2023 Jun 27;14:1176765. doi: 10.3389/fendo.2023.1176765. eCollection 2023.
本文引用的文献
1
A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Diabetes Care. 2020 Mar;43(3):597-606. doi: 10.2337/dc19-1922. Epub 2020 Jan 23.
2
Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months.
Pediatr Diabetes. 2020 Mar;21(2):319-327. doi: 10.1111/pedi.12971. Epub 2020 Jan 3.
3
6. Glycemic Targets: .
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76. doi: 10.2337/dc20-S006.
4
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.
5
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.
Diabetes Care. 2019 Dec;42(12):2190-2196. doi: 10.2337/dc19-0855. Epub 2019 Sep 23.
6
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes.
Acta Diabetol. 2020 Jan;57(1):101-104. doi: 10.1007/s00592-019-01398-3. Epub 2019 Aug 9.
7
Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
Diabetes Technol Ther. 2019 Sep;21(9):478-484. doi: 10.1089/dia.2019.0190. Epub 2019 Aug 1.
8
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8.
9
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18.
10
Insulin analogs: Glimpse on contemporary facts and future prospective.
Life Sci. 2019 Feb 15;219:90-99. doi: 10.1016/j.lfs.2019.01.011. Epub 2019 Jan 10.
Zotero 插件